These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9785983

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Elevated TNF-alpha and LDH without parathormone disturbance is associated with diffuse osteolytic lesions in leukemic transformation of myelofibrosis.
    Jurisic V, Terzic T, Pavlovic S, Colovic N, Colovic M.
    Pathol Res Pract; 2008; 204(2):129-32. PubMed ID: 17976926
    [Abstract] [Full Text] [Related]

  • 24. [Essential thrombocythemia transformed to myelofibrosis with myeloid metaplasia after seven years].
    Yamagishi M, Yamamoto T, Ohmori M.
    Rinsho Ketsueki; 1991 Mar; 32(3):239-43. PubMed ID: 2041165
    [Abstract] [Full Text] [Related]

  • 25. Primary myelofibrosis terminating in myeloblastic transformation within a short time.
    Yonemitsu H, Shigeta H, Kanazawa S, Yamaguchi K, Okuda K.
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):86-9. PubMed ID: 6947678
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Risk factors for leukemic transformation in patients with primary myelofibrosis.
    Huang J, Li CY, Mesa RA, Wu W, Hanson CA, Pardanani A, Tefferi A.
    Cancer; 2008 Jun 15; 112(12):2726-32. PubMed ID: 18404742
    [Abstract] [Full Text] [Related]

  • 33. [CD25 positive chronic eosinophilic leukemia with myelofibrosis].
    Saitoh T, Saiki M, Inoue M, Ishizuka H, Kura Y, Yamazaki T, Itoh T, Sawada U, Horie T.
    Rinsho Ketsueki; 2002 Oct 15; 43(10):918-23. PubMed ID: 12462027
    [Abstract] [Full Text] [Related]

  • 34. Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis.
    Rago A, Latagliata R, Montanaro M, Montefusco E, Andriani A, Crescenzi SL, Mecarocci S, Spirito F, Spadea A, Recine U, Cicconi L, Avvisati G, Cedrone M, Breccia M, Porrini R, Villivà N, De Gregoris C, Alimena G, D'Arcangelo E, Guglielmelli P, Lo-Coco F, Vannucchi A, Cimino G.
    Leuk Res; 2015 Mar 15; 39(3):314-7. PubMed ID: 25636356
    [Abstract] [Full Text] [Related]

  • 35. Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosis.
    Kreft A, Springer E, Lipka DB, Kirkpatrick CJ.
    Acta Haematol; 2009 Mar 15; 122(1):36-8. PubMed ID: 19713696
    [Abstract] [Full Text] [Related]

  • 36. Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia.
    Michiels JJ, Berneman Z, Schroyens W, Kutti J, Swolin B, Ridell B, Fernando P, Zanetto U.
    Ann Hematol; 2004 Aug 15; 83(8):504-12. PubMed ID: 15164229
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Podocalyxin is expressed in normal and leukemic monocytes.
    Riccioni R, Calzolari A, Biffoni M, Senese M, Riti V, Petrucci E, Pasquini L, Cedrone M, Lo-Coco F, Diverio D, Foà R, Peschle C, Testa U.
    Blood Cells Mol Dis; 2006 Aug 15; 37(3):218-25. PubMed ID: 17059890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.